Combining AI techniques to analyze tumor tissue

Researchers at SciLifeLab and Karolinska Institutet (KI) have combined AI techniques used in satellite imaging and community ecology to interpret large amounts of data from tumor tissue. The method, presented in the journal Nature Communications, could contribute to more personalized treatment of cancer patients.

While recent advances in tumor imaging provide a great insight into the microscopic world of tumors, the challenge is interpreting the vast amount of data generated. With hundreds of molecules being measured simultaneously in tens or hundreds of thousands of cells, it has become difficult for researchers to know what molecules and cells to focus on.

AI methods can help researchers analyze this avalanche of data and determine what to focus on. However, traditional AI, such as deep neural networks, often performs tasks without providing clear explanations that are understandable to humans. Details of how the process works are hidden or difficult to access in a so-called black box. The research team at Karolinska Institutet and SciLifeLab recognized the limitations of such methods and sought inspiration from other fields. They identified well-established analysis techniques in satellite imaging and ecology dating back to the 2000s and 1950s.

New AI methods are continuously developed to interpret data from satellite images, such as automatically identifying cities, lakes, forests, and deserts within large satellite images. In ecology, advanced techniques reveal how species of plants, animals, and microorganisms cohabit as communities within a given geographical area.

“We realized that the interpretation of tumor images is similar to the interpretation of satellite images and that the relationships between cells in a tissue are similar to the relationships between species in ecology,” explains SciLifeLab and KI researcher Jean Hausser, who led the research. “By combining techniques used in satellite imaging and ecology and adapting them for the analysis of tumor tissue, we have now been able to turn complex data into new insights into how cancer works.”

The next step is to apply the new method in clinical trials. The researchers are collaborating with a major cancer hospital in Lyon, France, to seek answers to why only some patients respond to cancer immunotherapy. In another collaboration with the Mayo Clinic in the US, they are investigating why some breast cancer patients don’t need chemotherapy.

“With our new method, we can reveal important details in tumor tissue that can determine whether a cancer treatment works or not. The long-term goal is to be able to tailor cancer treatments to individual needs and avoid unnecessary side effects,” says Jean Hausser.

The research was mainly funded by the Swedish Cancer Society, the Swedish Research Council, and SciLifeLab. There are no reported conflicts of interest.

DOI: 10.1038/s41467-023-42878-z

For more information, please contact: